The Global Non-Invasive Prenatal Testing Market Report presents an exhaustive analysis of the Non-Invasive Prenatal Testing market and offers investors, stakeholders and business strategists’ valuable insights on the forecast. It also studies the supply chain disruptions and economic volatility induced by the pandemic and offers a current and future assessment of the impact of the pandemic on the global and regional Non-Invasive Prenatal Testing market.
The global Non-Invasive Prenatal Testing market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research. Non-invasive prenatal testing (NIPT), commonly known as cell-free DNA testing, is regarded as a significant extension to the variety of diagnostic methods used to detect fetal chromosome defects. NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). NIPT enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes.
Get Free Sample PDF Brochure @ https://www.emergenresearch.com/request-sample/16
Competitive Outlook:
This section of the report performs a thorough investigation into the intensely competitive landscape of the global Non-Invasive Prenatal Testing market, highlighting the leading manufacturers, strategic initiatives adopted by them, the existing growth prospects, market positions, and market shares held by each participant. The report further emphasizes the developmental strategies undertaken by these companies, including product innovation, new product launches, and technological upgradation. Moreover, the report studies the notable business events observed in this industry, such as mergers acquisitions, joint ventures, partnerships, corporate deals, and brand promotions. The key industry participants include:
Key Companies Profiled in the Report are
Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera.
Report Highlights:
- Besides offering a vivid depiction of the global Non-Invasive Prenatal Testing business sphere and its fundamental operations, the latest report provides the industrial chain analysis and list down the current and future market trends and growth opportunities.
- The report includes information on the present and historical market scenarios, which helps forecast the market conditions over the next eight years (2020-2027).
- The report scrutinizes the salient factors influencing the growth of the market in the near future.
- The strategic marketing recommendations, crucial information related to the new market entrants, and expansion plans of various businesses are poised to provide the reader with a competitive edge in the market.
To know more about the report @ https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
The report analyzes the market based on different categories such as product types, end-user applications, and leading geographical regions. It offers key insights into the factors that are expected to influence the growth of the segments and sub-segments.
Non-Invasive Prenatal Testing Market Segmentation:
Method Outlook (Revenue, USD Billion; 2017-2027)
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-free DNA in Maternal Plasma Tests
- Others
End-Use Outlook (Revenue, USD Billion; 2017-2027)
- Diagnostic Laboratories
- Hospitals
- Research Centers
- Clinics
Application Outlook (Revenue, USD Billion; 2017-2027)
- Trisomy
- Microdeletion Syndrome
- Others
Key Geographies Profiled in the Report:
- North America(the U.S., Mexico, and Canada)
- Asia Pacific(China, Japan, India, and Rest of Asia Pacific)
- Europe(the U.K., France, Germany, and Rest of Europe)
- Latin America(Brazil and Rest of Latin America)
- Middle East Africa(GCC Countries and Rest of Middle East Africa)
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/16
Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.
Look Over transcripts provided by Emergen Research
Take a Look at OUR Reports:
construction sealants market
https://www.emergenresearch.com/industry-report/construction-sealants-market
ai-enabled medical imaging solutions market
https://www.emergenresearch.com/industry-report/ai-enabled-medical-imaging-solutions-market
gerd drugs and devices market
https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market
interventional oncology devices market
https://www.emergenresearch.com/industry-report/interventional-oncology-devices-market
water treatment biocides market
https://www.emergenresearch.com/industry-report/water-treatment-biocides-market
ai in banking market
https://www.emergenresearch.com/industry-report/ai-in-banking-market
computer aided diagnostics market
https://www.emergenresearch.com/industry-report/computer-aided-diagnostics-market
robotics surgical simulation systems market
https://www.emergenresearch.com/industry-report/robotics-surgical-simulation-systems-market
powered agriculture equipment market
https://www.emergenresearch.com/industry-report/powered-agriculture-equipment-market
collagen peptides market
https://www.emergenresearch.com/industry-report/collagen-peptides-market
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services